Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript - Thomson StreetEvents

Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript

Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript - Thomson StreetEvents
Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Published Jun 14, 2022
Published Jun 14, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RLMD.OQ presentation 14-Jun-22 5:40pm GMT

  
Report Type:

Transcript

Source:
Company:
Relmada Therapeutics Inc
Ticker
RLMD.OQ
Time
5:40pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Relmada Therapeutics Inc Q1 2023 Earnings Call Transcript – 2023-05-11 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 11-May-23 8:30pm GMT

Relmada Therapeutics Inc Q4 2022 Earnings Call Transcript – 2023-03-23 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 23-Mar-23 8:30pm GMT

Relmada Therapeutics Inc Top-line Results from Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder - Corporate Call Transcript – 2022-12-07 – US$ 54.00 – Edited Transcript of RLMD.OQ conference call or presentation 7-Dec-22 10:00pm GMT

Relmada Therapeutics Inc Q3 2022 Earnings Call Transcript – 2022-11-10 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 10-Nov-22 9:30pm GMT

Relmada Therapeutics Inc Q2 2022 Earnings Call Transcript – 2022-08-11 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 11-Aug-22 8:30pm GMT

Relmada Therapeutics Inc Q1 2022 Earnings Call Transcript – 2022-05-05 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 5-May-22 8:30pm GMT

Relmada Therapeutics Inc Q4 2021 Earnings Call Transcript – 2022-03-23 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 23-Mar-22 8:30pm GMT

Relmada Therapeutics Inc Results of Human Abuse Potential Study of REL-1017 vs. Ketamine - Corporate Call Transcript – 2022-02-23 – US$ 54.00 – Edited Transcript of RLMD.OQ conference call or presentation 23-Feb-22 1:30pm GMT

Relmada Therapeutics Inc Q3 2021 Earnings Call Transcript – 2021-11-11 – US$ 54.00 – Edited Transcript of RLMD.OQ earnings conference call or presentation 11-Nov-21 9:30pm GMT

Relmada Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-10 – US$ 54.00 – Edited Transcript of RLMD.OQ presentation 10-Sep-21 4:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript" Jun 14, 2022. Alacra Store. May 13, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Relmada-Therapeutics-Inc-at-Goldman-Sachs-Global-Healthcare-Conference-T15244293>
  
APA:
Thomson StreetEvents. (2022). Relmada Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript Jun 14, 2022. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Relmada-Therapeutics-Inc-at-Goldman-Sachs-Global-Healthcare-Conference-T15244293>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.